CHRISTOPHER JOSEPH VALLOROSI MD NPI 1245226828

NPI Details

Christopher Joseph Vallorosi, MD is an urology in Dover, DE with 31 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Christopher Joseph Vallorosi, MD NPI is 1245226828. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: HAHNEMANN UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:1995

The provider's business location address is:

200 BANNING ST
SUITE 250
DOVER, DE
ZIP 19904
Phone: (302) 736-1320
Fax: (302) 736-0769

The NPI 1245226828 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Automated urinalysis test (HCPCS:81003)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Electronic assessment of bladder emptying (HCPCS:51741)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Cell examination of urine, manual (HCPCS:88120)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Tissue marker, implantable, any type, each (HCPCS:A4648)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Biopsy of prostate gland (HCPCS:55700)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Unclassified drugs (HCPCS:J3490)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Placement of hormone pellet under skin (HCPCS:11980)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection of biodegradable material next to prostate (HCPCS:55874)
• Placement of device in prostate for radiation therapy (HCPCS:55876)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm (HCPCS:52234)
• Ultrasound scan of prostate through rectum (HCPCS:76873)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 9/20/2005 and was last updated on 9/5/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.